Here's the nasty reason why you should never trust the plastic hygiene liners on bathing suits
Although bathing suit bottoms usually have a plastic hygiene liner in them — according to a microbiologist, that's the last thing you want near your privates.
Nicholas Aicher is a scientist from Chicago. He took it upon himself to swab the plastic seal of two different bathing suit bottoms that hung in a retail store and place them into a petri dish to see what kind of bacteria live on them.
'I thought it would be fun for people to know all the little nastiness that we don't think about every day,' he told What's The Jam.
Once home, he transferred the samples to an incubator and let them sit for a bit before revealing some shocking, gross news.
The sample from one of the bathing suits had a high amount of Staphylococcus bacteria, which causes staph infections.
Common symptoms of staph infections include boils and oozing blisters, and they can turn fatal if the 'bacteria invade deeper into your body, entering your bloodstream, joints, bones, lungs or heart,' according to Mayo Clinic.
The results from the other sampled swimsuit were less severe, although it did have 'smaller pin-prick colonies' of the bacteria, according to Jam Press.
The moral of the story is to always try on bathing suits with some sort of barrier — whether it be full coverage underwear or tight-fitting pants, like leggings — between your skin and the fabric.
And bathing suits are not the only things to be wary of.
A TikToker (@onenevertwhoo_one), who only wanted to be referred to by his social media handle, contracted a skin infection most likely due to never washing the clothes he bought from a thrift store, according to Jam Press.
He explained in a video — that has since gone viral — that he contracted molluscum contagiosum, a viral skin infection that consists of small, raised, painless bumps on the skin.
Apparently the contagious condition that spreads through either skin-to-skin contact or contact with infected objects is harmless and does not require treatment, according to NeedToKnow.
Dr. Charles Puza, a board-certified NYC dermatologist, also reiterated in a TikTok video the importance of washing your clothes before putting them on, '…especially if you like fast fashion like Shein and Temu.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Latest ‘Tron: Ares' Trailer Features New Nine Inch Nails Song ‘Something to Believe In'
Ahead of next week's San Diego Comic Con Hall H panel, Disney has unleashed a new trailer for their forthcoming legacy sequel 'Tron: Ares,' from director Joachim Rønning, the latest installment of the franchise that began way back in 1982 with the cutting-edge 'Tron.' You can watch it below. No coins necessary. 'Tron: Ares,' which follows 2010's 'Tron: Legacy,' concerns a highly sophisticated program from the digital realm, Ares (Jared Leto), who crosses over into our world on what Disney is describing as a 'dangerous mission.' This will mark humanity's first encounter with A.I. beings. So far, the 'Tron' films have taken primarily in the computer world; it'll fun to see that world come into ours for the first time. More from TheWrap Latest 'Tron: Ares' Trailer Features New Nine Inch Nails Song 'Something to Believe In' Netflix Sets October Release for Edward Berger's 'Ballad of a Small Player' 'Fixed' Red Band Trailer Gives a Taste of Just How Naughty Netflix's Animated Dog Comedy Is Disney+ Sets First-Ever Live Stream of Premiere Event With 'The Fantastic Four: First Steps' Joining Leto on and off the grid are Greta Lee, Evan Peters (as Julian Dillinger, a name that might be familiar to fans of the franchise), Hasan Minhaj, Jodie Turner-Smith, Arturo Castro, Cameron Monaghan and Gillian Anderson (as another Dillinger). And, somewhat surprisingly, is the return of Jeff Bridges as Kevin Flynn. Flynn was the main character of the first movie, while the sequel featured Flynn and his digital alter-ego Clu. But both characters died at the end of 'Tron: Legacy,' which makes Bridges' return much more intriguing. (Bridges recently told Empire Magazine, 'As The Dude might say, new shit has come to light.') Of course, what makes this new 'Tron' installment even more exciting is the fact that Nine Inch Nails are doing the soundtrack. Previously, Trent Reznor and Atticus Ross have used their real names while composing the memorable scores to projects like David Fincher's 'The Social Network,' Pete Docter's 'Soul' and Luca Guadagnino's 'Challengers.' But this time they broke out their rock-and-roll moniker, and you can hear a taste of the first single from the 'Tron: Ares' soundtrack,' Something to Believe In,' in the trailer. Expect to hear much more about 'Tron: Ares' after next weekend's big Hall H presentation. 'Tron: Ares' hits theaters on Oct. 10. The post Latest 'Tron: Ares' Trailer Features New Nine Inch Nails Song 'Something to Believe In' appeared first on TheWrap.
Yahoo
12 minutes ago
- Yahoo
MYOS PET and Leading Veterinarian Urge Action as Weather Extremes Impact Senior Pet Muscle Health
CEDAR KNOLLS, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- With climate changes becoming more severe, veterinary sports medicine and rehabilitation expert Dr. Kelly Fishman, DVM, CVA, CCRT, warns that summer heat waves and winter freezes are silently accelerating muscle loss in senior pets. But, MYOS PET, a science-based muscle health brand, is helping veterinarians address the issue with nutrition-based solutions like Fortetropin®. 'Just like humans, dogs and cats naturally lose muscle mass as they age,' said Fishman, founder of Strut Animal Mobility Specialists and veterinary advisory board member at MYOS PET. 'But aging isn't the only cause—extended periods of inactivity, especially when pets are kept indoors due to extreme heat or cold, can also accelerate muscle loss.' To help prevent weather-related muscle loss and take proactive steps to support muscle health year-round, Fishman encourages pet parents to adjust exercise routines based on seasonal conditions. During hot summer months, dogs should be walked in the early morning or late evening, when temperatures are cooler. Choosing shaded, grassy areas can help reduce overheating and protect sensitive paw pads. On especially hot days, low-impact activities like swimming in a pool or creating an indoor obstacle course can keep pets moving without risking heat stress. In colder months, Fishman says preparing your dog's body for movement is important. Gentle spine stretching before going outside can help warm up muscles and reduce the risk of injury. Creating a winter-friendly exercise plan using resistance bands or core-strengthening exercises on stability balls helps improve balance and maintain muscle health in all seasons, Fishman recommends incorporating MYOS PET into treatment plans for aging and recovering pets. MYOS PET contains Fortetropin, a natural bioactive compound derived from fertilized raw egg yolk that has been shown to support muscle protein synthesis and reduce muscle loss.'I recommend MYOS PET with Fortetropin for many of the dogs I rehab and I use it on my own senior cat to improve his energy and mobility,' said Fishman. 'Fortetropin is one of the few tools we have that's backed by credible research and helps preserve muscle through every season.' In studies, Fortetropin has demonstrated benefits for both dogs and cats, including increased lean muscle mass and improved recovery after orthopedic surgery, without adverse side effects. It is increasingly being used by veterinarians to support long-term mobility in senior, post-surgical, and sedentary pets. A study published in Frontiers in Veterinary Science involving working dogs found that a rigorous endurance training program, including treadmill running and obstacle courses, conducted during the winter and spring months not only enhanced the dogs' athletic performance, but also improved their ability to tolerate heat in the summer. Researchers observed that the trained dogs developed a kind of internal 'thermostat,' enabling their bodies to activate cooling mechanisms, such as panting, more efficiently and at lower temperatures. This helped keep them cooler and reduced the risk of heat-related stress during warmer conditions. Fishman says the findings suggest that staying active does more than just build muscle and strength, it can also condition a dog's body to better regulate temperature, ultimately improving performance and safety during periods of extreme heat. For more information on maintaining your pet's muscle health year-round visit Photos accompanying this announcement are available at CONTACT: Media Contact: Amy Summers 212-757-3419 | amy@ Pitch Publicity®Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Medscape
14 minutes ago
- Medscape
AI Can Spot Lurking Heart Condition
Artificial intelligence can detect cardiac amyloidosis from a short video of a heartbeat, according to new research in the European Heart Journal . Cardiac amyloidosis results when misshaped or misfolded proteins lodge throughout the heart, forcing it to work harder to pump blood. The condition can lead to thicker heart walls, is more common in older adults, and has features similar to those of hypertensive heart disease or aortic stenosis. Diagnosis is challenging, particularly in earlier disease stages, when thicker heart walls are not apparent on an echocardiogram. 'If the patient has symptoms we can't explain and if the echo isn't quite normal, it would be reasonable to apply this AI model to see if they have amyloid,' said Patricia Pellikka, MD, the Betty Knight Scripps Professor of Cardiovascular Disease Clinical Research at Mayo Clinic in Rochester, Minnesota, and a co-author of the new study. Those symptoms could be nonspecific, such as shortness of breath, fatigue, or swollen ankles, Pellikka said. Cardiac amyloidosis is definitively diagnosed with a biopsy or blood and urine analysis. Although rare, the number of cases appears to be rising. The prevalence rate rose from 8 to 17 per 100,000 person-years from 2000 to 2012, according to an analysis published in Circulation: Heart Failure . A 2025 analysis by researchers at Mayo Clinic found an overall prevalence of cardiac amyloidosis of 1.25% among more than 30,000 people who received an echocardiogram, with a greater incidence in people aged 80-89 years than among those aged 60-69. 'Delays in diagnosis are very common with this disease,' said Jeremy Slivnick, MD, a cardiologist at the University of Chicago who helped conduct the latest research. In many cases, a year or more will elapse between the first appearance of symptoms and a diagnosis of amyloidosis, at which point the disease is harder to control, he said. Comparing AI to Other CA Screening Tools The new study validates previous research that led to the 2024 approval of the technology — EchoGo Amyloidosis — in the United States on a diverse population that spanned 18 global research sites. And the research shows that the AI model has broad applicability, Slivnick added. ''This is now an FDA-approved product,' Slivnick said. 'It's really critical that it works on everyone.' Pellikka and her colleagues at Mayo previously worked with Ultromics, the Oxford, UK-based biotech firm that markets EchoGo Amyloidosis, to create an AI algorithm that distinguishes cardiac amyloidosis from other types of heart disease. They fed video clips of echocardiograms of people diagnosed with the disorder into the tool, as well as video clips of people with other heart conditions. These clips showed the heart's four chambers during heartbeats. The new retrospective study tested the AI tool at 18 global sites, with 597 echo videos of people with cardiac amyloidosis and 2122 videos of people with other heart conditions. The AI model effectively spotted all subtypes of amyloidosis in the dataset, with an area under the receiver-operating characteristic curve (AUROC) of 0.93, a sensitivity of 85% for identifying patients with the condition, and a specificity of 93% for finding those without the disorder. An apical four-chamber view of a patient with newly diagnosed hereditary ATTR amyloidosis. The patient had presented with heart failure with preserved ejection fraction. This videoclip was among those used to build the model. Video courtesy of Mayo Clinic/Ultromics Compared with other commonly used diagnostic tests for the condition, including concentrations of transthyretin (which can form amyloid deposits) and measurements of cardiac wall thickness, the AI model spotted more cases of concern. The AUROC for the AI model was 0,93, compared to an AUROC of 0.73 for transthyretin concentration and an AUROC of 0.80 for increased mediation. 'Now we've got therapies for amyloid cardiomyopathy, but they work best if they're applied early in the natural history of the disease. We should be getting people on the treatment they need,' Pellikka said. Several options exist. The FDA has approved three drugs for the treatment of cardiac amyloidosis, each of which can stop further production of amyloid deposits but do not reverse the damage already done. These drugs are tafamidis (Vyndamax), acoramidis (Attruby), and vutrisiran (Amvuttra). Amyloidosis 'is a progressive disease. As of now we don't have anything to reverse the pathology, so the more protein that deposits in the heart, the worse these patients do,' said David Snipelisky, MD, an advanced heart failure and transplant cardiologist at Cleveland Clinic in Weston, Florida. Heart transplants are sometimes an option, Snipelisky said, but in other cases only the medications meant to stop amyloid production are possible. Representatives of any echo lab can upload video clips of suspected cases of cardiac amyloidosis to a secure site maintained by the company, Pellikka said, and receive a result of whether amyloidosis is likely, unlikely, or indeterminate. Although the latest findings show the potential of the algorithm to diagnose cardiac amyloidosis from a single echo image, the next step would be test the tool in a prospective clinical trial, Snipelisky said. Snipelisky reported no relevant financial conflicts of interest. Slivnick reported relationships with GE Healthcare, Pfizer, and BridgeBio. Pellikka reported funding from the National Institutes of Health, Ultromics, and Edwards Lifesciences.
